Resources

Explore our library of capabilities

Company Introduction

Integrated Drug Discovery

Target-based Drug Discovery

Therapeutic Areas

Technology Platforms

High-Throughput Affinity Selection Mass Spectrometry

Tumorigenicity Testing Services for Regenerative Medicine Products

Cardiac QT Risk Assessment Using a Human iPS-cardiomyocytes

Compound Screening Service using iPSC-derived Cells

Mini Kinase Panel 46

Therapeutic Modalities

We are ready to partner with you.